TITLE:
Surgery for Early Stage Invasive Cervical Cancer. Experience of the Oncology Department of Ledantec Hospital
AUTHORS:
Sidy Ka, Yaméogo Bonaventure, Mamadou M. Dieng, Souleymane Dieng, Jaafar Thiam, Salif Baldé, Ahmadou Dem
KEYWORDS:
Cancer, Cervix, Early, Treatment
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.13 No.2,
February
11,
2022
ABSTRACT: Background: Surgery is the treatment for early-stage cervical cancer.
Radiochemotherapy is used in the treatment of locally advanced stages. But the
choice of treatment can be difficult. Objective: The objective of this work was to evaluate the
therapeutic aspects of cervical cancer in the early stages IA to IIA in the
oncology department of A Ledantec Hospital in Dakar. Patients
and methods: This was a descriptive
retrospective study, from January 2015 to December 2020, in the oncology
department of A Ledantec Hospital, including all the patients who had been
treated for early-stage invasive cervical cancer. Results: We included 28 patients. The average age was 49.54
years old. There were 11 patients (39.3%) with a stage ≤ IB1. Surgery was the
first in 14 patients (50%). The initial approach was a midline supra and
subumbilical laparotomy. The surgery was R0 in 65.22%. Postoperative
complications were found in 4 patients including 1 case of operative wound
suppuration, 1 case of dysuria, 1 case of postoperative eventration and 1 case
of rectovaginal fistula. Concomitant Radiochemotherapy was neoadjuvant in 7
cases (25%), adjuvant in 14 cases (50%). The chemotherapy was neoadjuvant in 09
cases (56.25%) and adjuvant in 7 cases (43.75%) with minor toxicities. We had
recorded 2 deaths. Conclusion: The treatment of the early stages of invasive
cervical cancer is based on surgery. Neoadjuvant treatments may be useful in
particular situations.